- Home
- REAL vs NEO Comparison
REAL vs NEO Comparison
Compare REAL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- NEO
- Stock Information
- Founded
- REAL 2011
- NEO 2001
- Country
- REAL United States
- NEO United States
- Employees
- REAL N/A
- NEO N/A
- Industry
- REAL Other Specialty Stores
- NEO Precision Instruments
- Sector
- REAL Consumer Discretionary
- NEO Health Care
- Exchange
- REAL Nasdaq
- NEO Nasdaq
- Market Cap
- REAL 1.4B
- NEO 1.2B
- IPO Year
- REAL 2019
- NEO 1999
- Fundamental
- Price
- REAL $13.59
- NEO $11.38
- Analyst Decision
- REAL Buy
- NEO Buy
- Analyst Count
- REAL 8
- NEO 10
- Target Price
- REAL $13.94
- NEO $12.56
- AVG Volume (30 Days)
- REAL 4.9M
- NEO 3.1M
- Earning Date
- REAL 11-10-2025
- NEO 10-28-2025
- Dividend Yield
- REAL N/A
- NEO N/A
- EPS Growth
- REAL N/A
- NEO N/A
- EPS
- REAL N/A
- NEO N/A
- Revenue
- REAL $662,789,000.00
- NEO $709,162,000.00
- Revenue This Year
- REAL $14.56
- NEO $10.74
- Revenue Next Year
- REAL $10.14
- NEO $9.85
- P/E Ratio
- REAL N/A
- NEO N/A
- Revenue Growth
- REAL 14.30
- NEO 10.10
- 52 Week Low
- REAL $4.12
- NEO $4.72
- 52 Week High
- REAL $16.24
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- REAL 57.99
- NEO 67.22
- Support Level
- REAL $12.44
- NEO $10.36
- Resistance Level
- REAL $16.24
- NEO $11.52
- Average True Range (ATR)
- REAL 1.05
- NEO 0.54
- MACD
- REAL -0.04
- NEO 0.07
- Stochastic Oscillator
- REAL 53.91
- NEO 91.71
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.